Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
PUT
Neurocrine Biosciences
NBIX
$16.6B
| $9.75M | 0.01% |
79,300
-33,400
| -30% | -$3.79M |
|
1277
CoStar Group
CSGP
$12.3B
| $9.73M | 0.01% |
231,190
+30,640
| +15% | +$1.31M |
|
1278
CALL
AnaptysBio
ANAB
$1.68B
| $9.71M | 0.01% |
+97,300
| New | +$8.07M |
|
1279
Jazz Pharmaceuticals
JAZZ
$16.7B
| $9.69M | 0.01% |
57,593
+31,413
| +120% | +$5.4M |
|
1280
PUT
MetLife
MET
$62.1B
| $9.69M | 0.01% |
207,300
+24,000
| +13% | +$1.1M |
|
|
ACC
1281
DELISTED
American Campus Communities, Inc.
ACC
| $9.68M | 0.01% |
235,145
+14,910
| +7% | +$624K |
|
1282
PUT
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
| $9.63M | 0.01% |
166,200
+56,400
| +51% | +$3.1M |
|
1283
Banco Bradesco
BBD
$36.7B
| $9.58M | 0.01% |
2,161,208
+1,335,323
| +162% | +$6.15M |
|
|
RHT
1284
CALL
DELISTED
Red Hat Inc
RHT
| $9.58M | 0.01% |
70,300
-42,700
| -38% | -$6.11M |
|
1285
PUT
Dick's Sporting Goods
DKS
$18.7B
| $9.57M | 0.01% |
269,800
-26,500
| -9% | -$950K |
|
|
SVC
1286
Service Properties Trust
SVC
$1.07B
| $9.57M | 0.01% |
66,368
+10,425
| +19% | +$1.49M |
|
|
EXAS
1287
CALL
DELISTED
Exact Sciences
EXAS
| $9.56M | 0.01% |
121,200
-38,600
| -24% | -$2.52M |
|
1288
Factset
FDS
$10.2B
| $9.54M | 0.01% |
42,646
+23,460
| +122% | +$5.09M |
|
|
AXON
1289
Axon Enterprise
AXON
$46.4B
| $9.54M | 0.01% |
139,400
+67,618
| +94% | +$4.56M |
|
1290
CALL
General Mills
GIS
$19.7B
| $9.51M | 0.01% |
221,500
-21,600
| -9% | -$978K |
|
|
STMP
1291
DELISTED
Stamps.com, Inc.
STMP
| $9.5M | 0.01% |
42,013
+26,592
| +172% | +$6.65M |
|
|
IMMU
1292
DELISTED
Immunomedics Inc
IMMU
| $9.5M | 0.01% |
456,205
+121,519
| +36% | +$2.88M |
|
1293
Hormel Foods
HRL
$13.8B
| $9.5M | 0.01% |
241,100
+2,752
| +1% | +$105K |
|
1294
CALL
Ulta Beauty
ULTA
$24.3B
| $9.48M | 0.01% |
33,600
+15,700
| +88% | +$4M |
|
|
CHK
1295
DELISTED
Chesapeake Energy Corporation
CHK
| $9.47M | 0.01% |
10,543
+253
| +2% | +$231K |
|
1296
PUT
MasTec
MTZ
$21.9B
| $9.44M | 0.01% |
211,400
+181,700
| +612% | +$8.41M |
|
1297
CALL
Las Vegas Sands
LVS
$29.6B
| $9.4M | 0.01% |
158,400
-39,600
| -20% | -$2.66M |
|
|
BDN
1298
Brandywine Realty Trust
BDN
$554M
| $9.4M | 0.01% |
597,729
+88,700
| +17% | +$1.46M |
|
1299
DexCom
DXCM
$32B
| $9.39M | 0.01% |
262,708
+36,512
| +16% | +$1.13M |
|
1300
Chord Energy
CHRD
$7.39B
| $9.38M | 0.01% |
661,630
+66,128
| +11% | +$837K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.